References
- Centers for Disease Control and Prevention. Pertussis–United States, 1997-2000. MMWR 2002; 51:73-76; PMID:11837909
- Healthychildren.org. (2012) Whooping cough. Available from: http://www.healthychildren.org/English/health-issues/vaccine-preventable-diseases/pages/Whooping-Cough-(Pertussis).aspx. Accessed 22 October 2013.
- Centers for Disease Control and Prevention. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use–supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1992; 41:1-10.
- Centers for Disease Control and Prevention. General recommendations on immunization — recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011; 60:1-64.
- Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years–United States, 2013. MMWR Surveill Summ 2013; 62(Suppl 1):2-8; PMID:23364302
- Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months–United States, 2011. MMWR 2012; 61:689-696; PMID:22951450
- Centers for Disease Control and Prevention. Estimated Vaccination Coverage with Individual Vaccines and Selected Vaccination Series Among Children 19-35 Months of Age by State US, National Immunization Survey, Q1/2010-Q4/2010. Available from: http://www2a.cdc.gov/nip/coverage/nis/nis_iap3.asp?fmt=v&rpt=tab03_antigen_state&qtr=Q1/2010-Q4/2010. Accessed 22 October 2013
- Roehr B. Whooping cough outbreak hits several US states. Br Med J 2010; 341:c4627; http://dx.doi.org/10.1136/bmj.c4627
- Cherry JD. Epidemic pertussis in 2012–the resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367:785-7; PMID:22894554; http://dx.doi.org/10.1056/NEJMp1209051
- Cherry JD. The science and fiction of the “resurgence” of pertussis. Pediatrics 2003; 112:405-6; PMID:12897292; http://dx.doi.org/10.1542/peds.112.2.405
- Broutin H, Guegan JF, Elguero E, Simondon F, Cazelles B. Large-scale comparative analysis of pertussis population dynamics: periodicity, synchrony, and impact of vaccination. Am J Epidemiol 2005; 161:1159-67; PMID:15937025; http://dx.doi.org/10.1093/aje/kwi141
- Centers for Disease Control and Prevention. Pertussis (whooping cough) surveillance & reporting 2012 8/16/2012 [cited 1/4/2013]; Available from: http://www.cdc.gov/pertussis/surv-reporting.html. Accessed 22 October 2013
- Sanofi Pasteur. DAPTACEL (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) prescribing information. Available from: https://www.vaccineshoppe.com/image.cfm?doc_id=11179&image_type=product_pdf. Accessed 22 October 2013
- Sanofi Pasteur. Diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed: Tripedia [prescribing information]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM101580.pdf. Accessed 22 October 2013
- GlaxoSmithKline Biologicals. Infanrix: diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed [prescribing Information]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM124514.pdf. Accessed 22 October 2013
- Sanofi Pasteur. Haemophilus b conjugate vaccine (tetanus toxoid conjugate) ActHIB [prescribing information]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109841.pdf. Accessed 22 October 2013
- GlaxoSmithKline Biologicals. PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined] Prescribing information. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241874.pdf. Accessed 22 October 2013
- Sanofi Pasteur. PENTACEL [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine] prescribing information. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM109810.pdf. Accessed 22 October 2013
- GlaxoSmithKline Biologicals. KINRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine) prescribing information. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM241453.pdf. Accessed 22 October 2013
- Halperin SA, McNeil S, Langley J, Blatter M, Dionne M, Embree J, Johnson R, Latiolais T, Meekison W, Noya F, et al. Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4–5 years after a previous dose. Vaccine 2011; 29:8459-65; PMID:21803091; http://dx.doi.org/10.1016/j.vaccine.2011.07.068
- Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Atkinson W, Hamborsky J, Wolfe S, eds. 12th ed., second printing. Washington DC: Taylor & Francis, 2012
- Langley JM, Halperin SA, Rubin E, White C, McNeil S, Mutch J, Mackinnon-Cameron D, Smith B. Safety and immunogenicity of 2 mixed primary infant immunization schedules of pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, and Haemophilus influenzae Type B vaccines at 2, 4, and 6 months of age: a randomized controlled trial. Ped Inf Dis J 2012; 31:189-92; PMID:22173143; http://dx.doi.org/10.1097/INF.0b013e318242462a
- Greenberg DP, Pickering LK, Senders SD, Bissey JD, Howard RA, Blatter MM, Reisinger K, Pichichero ME, Howe BJ. Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy. Pediatrics 2002; 109:666-72; PMID:11927713; http://dx.doi.org/10.1542/peds.109.4.666
- Von König CH, Herden P, Palitzsch D, Schneeweiss B, Bier N. Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization. Pediatr Infect Dis J 2000; 19:757-59; PMID:10959748; http://dx.doi.org/10.1097/00006454-200008000-00018
- Centers for Disease Control and Prevention. Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage — National Immunization Survey, United States, 2009. MMWR 2010; 59:1069-72
- Santibanez TA, Santoli JM, Barker LE. Differential effects of the DTaP and MMR vaccine shortages on timeliness of childhood vaccination coverage. Am J Publ Health 2006; 96:691-6; http://dx.doi.org/10.2105/AJPH.2004.053306
- National Committee for Quality Assurance (NCQA). The state of health care quality 2012: focus on obesity and on Medicare plan improvement. Available from: http://www.ncqa.org/Portals/0/State%20of%20Health%20Care/2012/SOHC%20Report%20Web.pdf. Accessed 1/4/2013
- Zell ER, Ezzati-Rice TM, Battaglia MP, Wright RA. National immunization survey: the methodology of a vaccination surveillance system. Publ Health Rep 2000; 115:65-77; http://dx.doi.org/10.1093/phr/115.1.65
- Health insurance portability and accountability act of 1996. Public law 104-191, 104th Congress. Available from: http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf. Accessed 22 October 2013
- Sanofi-aventis. Letter to providers. Available from: http://www.vaccines.mil/documents/1398SanofiPasteur_Trpedia_TriHIBitLtr.pdf. Accessed 22 October 2013